RE:RE:RE:RE:Persuade me? Yeah, I voted NO on all resolutions.
In this market, CRH is worth quite a bit more than $4 US
bfw
raglo wrote: there was never a real true 80% premium, it was a very opportunistic offer and Management was too quick to accept, only reason it was trading at the level when offer was made wass because of the cancellation letter from UD,
CRHM was trading at $2.90 prior to news of UD letter, so at best the offer was
only a 40% premium at the time and since the 3 recent deals we would probably be trading above the offer price,and this from the statement when news of of the UD letter was annouced:
"CRH assumed most of these professional service agreements upon our acquisition of Gastroenterology Anesthesia Associates in 2014," said Tushar Ramani , CEO. "We have since changed our partnership model and have developed an entire anesthesia business apart from this initial acquisition, to the point where UD represents a smaller, albeit important, part of our business today. We believe that we can replace much of this EBITDA through acquisitions and organic growth throughout 2021, and mitigate the potential financial impact in 2022."
So what changed management and BOD opinion on the fairness of the offer ? I for one believe that there is more value to shareholders in staying independent.